The Indian government is exploring a proposal to reduce the limit on foreign direct investment (FDI) allowed in the pharmaceutical industry through the automatic route to 49% from 100% amid concerns over the takeover of local drug makers by overseas firms. Officials from the ministry of commerce and industry and the ministry of health have had multiple rounds of discussions on the proposal following a note written to them by the finance...

The report of the Javid Chowdhury Committee facilitated the resumption, in February 2010, of vaccine production in the three public sector units, one in Himachal Pradesh and the other two in Tamil Nadu. Javid Chowdhury, a former Health Secretary of the Government of India, recommended that the suspension of their licenses for manufacturing vaccines in 2008 should be revoked in the public interest and on the strength of the compliance...

In most organisations, those who are the biggest funders are also the ones with the biggest say in their running. In the case of the World Health Organisation (WHO), on the face of it, there seem to be two entities making the biggest voluntary contributions, the US government and the Bill and Melinda Gates Foundation. But a closer look at the list of voluntary contributors suggests that the Gates Foundation...

If recent indicators are anything to go by – the failure to keep food prices down, the proposed national food security Act, the failure to ensure even minimum wages to construction workers at projects for the upcoming Commonwealth Games in New Delhi, to recount a few – it seems the country has given up even the pretence of caring about its children or their crippling, unbudging state of malnutrition. Leaders,...

India has played a crucial role in making essential medicines available and affordable for patients in the developing world through generic drugs. This has been possible by linking India’s patent policies and laws to public interest. Similarly, policies that align public funded R&D in India with public health have the potential to provide incentives to the development of medical technologies (vaccines, diagnostics and medicines) crucial for treating neglected diseases like...